Using whole exome sequencing to explore germline variation in BRCA1/BRCA2/PALB2 negative contralateral breast cancers from the Women's Environmental Cancer and Radiation Epidemiology (WECARE) study

被引：0

作者：

Larionov, A.

Fewings, E.

Redman, J.

Goldgraben, M.

Hadfield, J. ^{[1
]}

Concannon, P. ^{[2
]}

Bernstein, J. ^{[3
]}

Conti, D. ^{[4
]}

Tischkowitz, M.

机构：

[1] Canc Res UK Cambridge Inst, Cambridge, England

[2] Univ Florida, Gainesville, FL USA

[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[4] Univ Southern Calif, Los Angeles, CA USA

来源：

EUROPEAN JOURNAL OF HUMAN GENETICS | 2018年 / 26卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

P12.010B

引用

页码：517 / 517

页数：1

共 50 条

[31] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer [J].

Wong-Brown, Michelle W. ;

Meldrum, Cliff J. ;

Carpenter, Jane E. ;

Clarke, Christine L. ;

Narod, Steven A. ;

Jakubowska, Anna ;

Rudnicka, Helena ;

Lubinski, Jan ;

Scott, Rodney J. .

BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) :71-80

[32] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer [J].

Michelle W. Wong-Brown ;

Cliff J. Meldrum ;

Jane E. Carpenter ;

Christine L. Clarke ;

Steven A. Narod ;

Anna Jakubowska ;

Helena Rudnicka ;

Jan Lubinski ;

Rodney J. Scott .

Breast Cancer Research and Treatment, 2015, 150 :71-80

[33] PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations [J].

Jin Ho Kim ;

Doo Ho Choi ;

Dae Yeon Cho ;

Sei Hyun Ahn ;

Byung Ho Son ;

Bruce G. Haffty .

Breast Cancer Research and Treatment, 2010, 122 :303-306

[34] Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada [J].

Hartley, Taila ;

Cavallone, Luca ;

Sabbaghian, Nelly ;

Silva-Smith, Rachel ;

Hamel, Nancy ;

Aleynikova, Olga ;

Smith, Erika ;

Hastings, Valerie ;

Pinto, Pedro ;

Tischkowitz, Marc ;

Tomiak, Eva ;

Foulkes, William D. .

HEREDITARY CANCER IN CLINICAL PRACTICE, 2014, 12

[35] Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada [J].

Taila Hartley ;

Luca Cavallone ;

Nelly Sabbaghian ;

Rachel Silva-Smith ;

Nancy Hamel ;

Olga Aleynikova ;

Erika Smith ;

Valerie Hastings ;

Pedro Pinto ;

Marc Tischkowitz ;

Eva Tomiak ;

William D Foulkes .

Hereditary Cancer in Clinical Practice, 12

[36] Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study [J].

Jane C. Figueiredo ;

Robert W. Haile ;

Leslie Bernstein ;

Kathleen E. Malone ;

Joan Largent ;

Bryan Langholz ;

Charles F. Lynch ;

Lisbeth Bertelsen ;

Marinela Capanu ;

Patrick Concannon ;

Ake Borg ;

Anne-Lise Børresen-Dale ;

Anh Diep ;

Sharon Teraoka ;

Therese Torngren ;

Shanyan Xue ;

Jonine L. Bernstein .

Breast Cancer Research and Treatment, 2010, 120 :175-183

[37] Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants [J].

Lucas, Aimee L. ;

Fu, Yichun ;

Labiner, Arielle J. ;

Dimaio, Christopher J. ;

Sethi, Amrita ;

Kastrinos, Fay .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (10) :2686-2688

[38] PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations [J].

Kim, Jin Ho ;

Choi, Doo Ho ;

Cho, Dae Yeon ;

Ahn, Sei Hyun ;

Son, Byung Ho ;

Haffty, Bruce G. .

BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (01) :303-306

[39] Germline mutations in cancer susceptibility genes in BRCA1 and BRCA2 negative families with ovarian and breast cancer [J].

Norquist, B. ;

Harrell, M. ;

Walsh, T. ;

Mandell, J. ;

Bernards, S. ;

Agnew, K. ;

Lee, M. ;

Pennington, K. ;

King, M. C. ;

Swisher, E. .

CLINICAL CANCER RESEARCH, 2015, 21

[40] Germline mutations in cancer susceptibility genes in brca1 and brca2 negative families with ovarian and breast cancer [J].